Home > Press > Keystone Nano selected as a top scoring company by NCI investor review panel
Abstract:
Keystone Nano is pleased to announce that it has been selected for additional support from the National Cancer Institute of the National Institutes of Health. After a careful and competitive review by a National Cancer Institute (NCI) panel looking for leading investment opportunities among Small Business Innovation Research (SBIR) awardees, Keystone Nano was selected as a top scoring applicant and has been awarded support for business development.
Keystone Nano selected as a top scoring company by NCI investor review panel
State College, PA | Posted on July 19th, 2016“Keystone Nano is pleased to be selected as one of the leading NCI SBIR funded companies of 2016. We are grateful that NCI has recognized the value of our work and the approach we are taking. This selection further validates the commercial opportunities associated with our products and technologies”, remarked Mr. James Sharpe, Keystone Nano’s Vice President of Business Development.
####
About Keystone Nano
Based in State College, PA, Keystone Nano is working at the interface between nanotechnology and the life sciences. The company is commercializing Ceramide NanoLiposome for the treatment of cancer, and is developing additional products using NanoJackets, non-toxic calcium phosphate nanoparticles that can be targeted to specific cell types and can deliver a wide range of materials from classical chemotherapeutics to siRNA and mRNA. The Company’s product pipeline is protected by a patent portfolio comprised of 11 patent families that has resulted in 14 issued patents and 8 pending applications to date.
For more information about Keystone Nano, our products and our technology, visit our website www.keystonenano.com, or contact Jeff Sirianni at .
For more information, please click here
Contacts:
Jeff Sirianni at
t: @Keystonenano
Copyright © Keystone Nano
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
| Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Cancer
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024
Atomic force microscopy in 3D July 5th, 2024
Aston University researcher receives £1 million grant to revolutionize miniature optical devices May 17th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||